MiRNome and transcriptome aided pathway analysis in human regulatory T cells.

Area of Science:

• Immunology
• Molecular Biology
• Systems Biology

Background:

• Regulatory T cells (Treg) possess critical immune regulatory functions, making them significant targets for treating immunological diseases and cancer.
• Understanding the intrinsic molecular programs governing Treg function is essential for their directed therapeutic manipulation.

Purpose of the Study:

• To simultaneously analyze microRNA (miR) and messenger RNA (mRNA) transcript levels in human Treg and conventional T cells (Tcon).
• To integrate miR and mRNA data with validated miR-target information for comprehensive pathway analysis.
• To identify key signaling pathways in Treg biology and predict their activity based on transcript levels.

Main Methods:

• Simultaneous analysis of miR and mRNA transcript levels in resting and activated human Treg and Tcon cells.
• Integration of transcriptomic data with experimentally validated miR-target interactions.
• Comprehensive pathway analysis to identify characteristic signaling networks in Treg cells.

Main Results:

• Identified characteristic signal transduction pathways in Treg biology, including T-cell receptor, Toll-like receptor, transforming growth factor-β, JAK/STAT, and mTOR signaling.
• Developed a probabilistic model to predict specific pathway activities based on miR and mRNA transcript levels.
• Revealed distinct molecular signatures differentiating Treg from Tcon cells.

Conclusions:

• The study provides a comprehensive molecular framework for understanding Treg intrinsic programs.
• The findings enable the prediction of Treg pathway activities, paving the way for targeted therapeutic strategies.
• These insights support new concepts for controlling Treg cell effector functions in immunological pathologies and cancer.